28/06/2022 - General information
This is a study on the impact of the COVID-19 pandemic on the breast cancer screening program. Its main author is Dr. Guillem Bosch, resident physician of the PSMAR-UPF-ASPB Teaching Unit and member of the Health Services Research Group of the Hospital del Mar Medical Research Institute.
17/06/2022 - Institutional news
IMIM-Hospital del Mar is committed to attracting scientific talent of excellence and young researchers through IMIM-OpenLAB. The initiative provides fully equipped facilities and young scientists who choose to take advantage of this opportunity are guaranteed initial funding. The centre has set up a new laboratory area with the intention of facilitating transversal and multidisciplinary work and promoting the incorporation of new researchers who are committed to undertaking or continuing their research in the biomedical cluster comprising the IMIM, Hospital del Mar and the PRBB environment. A space in which the Immune Redirection Research Group is already at work, focusing on the identification of specific alterations in tumour cells that can be used as therapeutic targets for new anti-cancer treatments, such as immunotherapy.
Més informació "IMIM-Hospital del Mar's cutting-edge research is strengthened"
17/06/2022 - Institutional news
The Friends of the Hospital del Mar Foundation and APRO, the Association for Oncological Research, have awarded Dr. Edurne Arriola more than 8,000 euros to boost immunotherapy and lung cancer research being carried out at Hospital del Mar and the Hospital del Mar Medical Research Institute. Lung cancer research at Hospital del Mar and the Hospital del Mar Medical Research Institute has received a new boost thanks to the Friends of the Hospital del Mar Foundation and APRO, the Association for Oncological Research. The two organisations have managed to raise 8,000 euros, which will be used to support the work of researchers in this field.
14/06/2022 - General information
It is published by Triacastela Publishing House. In it, Dr. Porta explains, in an easy and entertaining way, current epidemiological and public health issues, such as the management by governments of the COVID-19 pandemic. Epidemiology and epidemiologists have been in vogue over the last two years, when SARS-CoV-2 and COVID-19 have made all the headlines. A medical and scientific discipline that studies and acts on populations and groups of people under real conditions, which is carried out outside laboratories.
Més informació "Epidemiología cercana, the new book by Dr. Miquel Porta"
31/05/2022 - Institutional news
The hospital is the only healthcare centre in Spain to form part of the group behind the project, which aims to create a mobile app platform to personalise patient monitoring for sufferers of this disease. The initiative will receive funding from the EU's HORIZON programme. Hospital del Mar's Pneumology Department is part of the TOLIFE project (Artificial Intelligence and Smart sensing TOward better management and improved quality of LIFE in chronic obstructive pulmonary disease). This is an international initiative to develop a tool that, using artificial intelligence, will improve and personalise the treatment of patients with chronic obstructive pulmonary disease (COPD).
30/05/2022 - Press release
A group of genes has been identified in cancerous cells that survive chemotherapy treatment. The activity of these genes leads to treatment resistance and increased capacity for metastasis. This breakthrough opens the door to studying targeted treatments using drug inhibitors of these genes combined with chemotherapy, potentially providing alternatives for patients with a worse prognosis in this type of tumor, accounting for 30% of cases. The research, led by scientists from the Hospital del Mar Medical Research Institute, highlights that this type of tumor cell reverts to an embryonic state. Identifying the factor that triggers this change could aid in designing new treatments for high-risk patients.
23/05/2022 - Events
Research and knowledge take to the streets again with the 15th Science Festival organized by the Barcelona City Council. Next May 28th and 29th 200 activities, 27 different spaces and more than 150 entities of the city related to science and outreach are waiting for you in the Rambla del Raval. In this sense, the Hospital del Mar Medical Research Institute (IMIM) invites you to the debate on "Animal Experimentation in Science" that organizes and that will take place on Saturday May 28 at 20:00h. The participants of the debate will be: Arnau Busquets: moderator and researcher with animal models at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar). Sergi Vila: member of the Agreement on transparency in animal experimentation COSCE (Confederation of Spanish Scientific Societies). Domingo Gargallo: co-founder and vice-president of REMA (Spanish Network for the Development of Alternative Methods in Animal Experimentation).
Més informació "Debate "Animal experimentation in science" - May 28th (15th Science Festival)"
18/05/2022 - Covid-19
A study by doctors and researchers at Hospital del Mar and the Hospital del Mar Medical Research Institute confirms that COVID-19 infection is much more virulent than the flu in this group of patients, despite the fact that they are younger and in better health. They also require longer hospital stays and more care. This means that the price of their treatment is double that of patients admitted for influenza, with an extra cost of almost 10,000 euros. The study has been published in the journal Clinical Infectious Diseases and presented at the European Congress of Microbiology and Infectious Diseases held in Lisbon.
13/05/2022 - General information
A platform developed by the Centre Nacional d'Anàlisi Genòmica (CNAG-CRG) allows doctors and researchers from Catalan hospitals to share data and otherwise scattered expertise and diagnose patients with neurologic rare diseases. During the pilot project, a diagnosis was provided to 67 out of 323 patients (20.7% of cases), just by reanalysing previously available data. The results constitute an important milestone for ending the 'diagnostic odyssey' faced by patients in Catalonia. The collaborative approach also resulted in the identification of six new genes linked to specific diseases, which will make it easier to diagnose certain diseases in the future. The results, published today in The Journal of Molecular Diagnostics, were possible thanks to the Undiagnosed Rare Disease Program of Catalonia (URD-Cat), funded by the Departament de Salut de la Generalitat de Catalunya. The URD-Cat project was coordinated by the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and involved more than 140 professionals from 15 different research centres and hospitals.
Més informació "Catalan collaboration helps end ‘diagnostic odyssey’ for rare disease patients"
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
